BR9709062A - Composto, composição farmacêutica, e, uso de um composto. - Google Patents
Composto, composição farmacêutica, e, uso de um composto.Info
- Publication number
- BR9709062A BR9709062A BR9709062-0A BR9709062A BR9709062A BR 9709062 A BR9709062 A BR 9709062A BR 9709062 A BR9709062 A BR 9709062A BR 9709062 A BR9709062 A BR 9709062A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- hydroxyandrosta
- androstenes
- dichloroacetoxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 150000001443 androstenes Chemical class 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1710296P | 1996-05-09 | 1996-05-09 | |
PCT/US1997/006812 WO1997042214A1 (en) | 1996-05-09 | 1997-05-01 | Androstene derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9709062A true BR9709062A (pt) | 2000-01-04 |
Family
ID=21780726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9709062-0A BR9709062A (pt) | 1996-05-09 | 1997-05-01 | Composto, composição farmacêutica, e, uso de um composto. |
Country Status (20)
Country | Link |
---|---|
US (1) | US5981517A (pt) |
EP (1) | EP0902789B1 (pt) |
JP (1) | JP3328938B2 (pt) |
CN (1) | CN1144812C (pt) |
AT (1) | ATE212351T1 (pt) |
AU (1) | AU721622B2 (pt) |
BR (1) | BR9709062A (pt) |
CA (1) | CA2254079C (pt) |
CZ (1) | CZ292860B6 (pt) |
DE (1) | DE69710065T2 (pt) |
DK (1) | DK0902789T3 (pt) |
ES (1) | ES2171933T3 (pt) |
HK (1) | HK1021539A1 (pt) |
HU (1) | HUP9902449A3 (pt) |
NO (2) | NO311646B1 (pt) |
NZ (1) | NZ332608A (pt) |
PL (1) | PL186637B1 (pt) |
PT (1) | PT902789E (pt) |
RU (1) | RU2194053C2 (pt) |
WO (1) | WO1997042214A1 (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066561A1 (fr) * | 2000-03-09 | 2001-09-13 | Kissei Pharmaceutical Co., Ltd. | Medicaments preventifs ou therapeutiques contre des maladies des yeux |
CA2417825C (en) * | 2000-08-05 | 2008-07-22 | Glaxo Group Limited | 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6858593B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777400B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
DE60113145T2 (de) * | 2000-11-03 | 2006-06-22 | The University Of Manchester | Selektive glucocorticoid rezeptor agonisten |
UA77656C2 (en) * | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
US7291608B2 (en) * | 2001-04-30 | 2007-11-06 | Glaxo Group Limited | Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α |
US20040248867A1 (en) * | 2001-06-12 | 2004-12-09 | Keith Biggadike | Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
WO2004112800A1 (en) * | 2003-06-19 | 2004-12-29 | Bodor Nicholas S | Enhancement of activity and/or duration of action of selected anti-inflammatory steroids |
JP4893305B2 (ja) * | 2003-06-19 | 2012-03-07 | ボーダー、ニコラス・エス | 局所又は他の局部投与用のソフト抗炎症性ステロイドの活性及び/又は作用持続性の増強 |
CN100450488C (zh) * | 2003-11-03 | 2009-01-14 | 诺顿·希尔思凯尔有限公司 | 用于干粉吸入剂的软类固醇组合物 |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
TWI374147B (en) * | 2006-01-27 | 2012-10-11 | Sun Pharma Advance Res Company Ltd | Novel 11β-hydroxyandrosta-4-ene-3-ones |
US7691811B2 (en) * | 2006-05-25 | 2010-04-06 | Bodor Nicholas S | Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
US7687484B2 (en) * | 2006-05-25 | 2010-03-30 | Bodor Nicholas S | Transporter enhanced corticosteroid activity |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
WO2018232007A1 (en) | 2017-06-13 | 2018-12-20 | Bodor Laboratories, Inc. | Potent soft anti-inflammatory corticosteroid compounds and uses therof |
CN111100176A (zh) * | 2019-12-20 | 2020-05-05 | 重庆华邦胜凯制药有限公司 | 一种化合物的制备方法 |
WO2024149093A1 (zh) * | 2023-01-10 | 2024-07-18 | 四川科伦博泰生物医药股份有限公司 | 糖皮质激素受体激动剂及其偶联物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE135476C (pt) * | ||||
US3258473A (en) * | 1963-10-04 | 1966-06-28 | Syntex Corp | 17-dihaloacetate esters of 17alpha-hydroxy-21-desoxypregnane derivatives |
US3636010A (en) * | 1968-12-23 | 1972-01-18 | Ciba Geigy Corp | Esters of steroid-17-carboxylic acids |
GB1384372A (en) * | 1971-01-20 | 1975-02-19 | Glaxo Lab Ltd | Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids |
US3828080A (en) * | 1972-01-20 | 1974-08-06 | Glaxo Lab Ltd | Androstane-17beta-carboxylic acids and processes for the preparation thereof |
GB1438940A (en) * | 1972-07-19 | 1976-06-09 | Glaxo Lab Ltd | 17beta-haloalkoxycarbonyl-17alpha-oxysteroids |
US4093721A (en) * | 1974-08-30 | 1978-06-06 | Glaxo Laboratories Limited | Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof |
CH628355A5 (de) * | 1976-02-24 | 1982-02-26 | Ciba Geigy Ag | Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze. |
GB2014579B (en) * | 1978-02-08 | 1982-08-25 | Glaxo Group Ltd | Chloromethyl 17 acetoxy fluoro hydroxy 16 methyl 3 oxoandrosta 1,4 diene 17 carboxylate |
US4198403A (en) * | 1978-04-05 | 1980-04-15 | Syntex (U.S.A.) Inc. | 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes |
US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
US4263289A (en) * | 1978-04-05 | 1981-04-21 | Syntex (U.S.A.) Inc. | Thio etianic acid derivatives |
BE887518A (fr) * | 1980-02-15 | 1981-08-13 | Glaxo Group Ltd | Cartothioates d'androstanes |
US4578221A (en) * | 1980-04-23 | 1986-03-25 | Glaxo Group Limited | Androstane carbothioic acids |
US4710495A (en) * | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
US4996335A (en) * | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
US4607028A (en) * | 1983-08-18 | 1986-08-19 | Ciba-Geigy Corporation | Novel carboxylic acid esters |
FR2551069B1 (fr) * | 1983-08-26 | 1986-07-25 | Jouveinal Sa | 17-oxo-21-thioesters d'hydrocortisone, leur preparation et leurs applications comme medicament |
JPS617291A (ja) * | 1984-06-20 | 1986-01-13 | Mitsubishi Chem Ind Ltd | 新規なコルチコイド誘導体およびその製法 |
PT78973A (en) * | 1984-07-25 | 1984-08-01 | Joao Emerico Villax | New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid |
US5223493A (en) * | 1984-12-28 | 1993-06-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
DE4025342A1 (de) * | 1990-08-10 | 1992-02-13 | Hoechst Ag | In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel |
-
1997
- 1997-04-24 US US08/840,038 patent/US5981517A/en not_active Expired - Fee Related
- 1997-05-01 PL PL97329802A patent/PL186637B1/pl not_active IP Right Cessation
- 1997-05-01 CA CA002254079A patent/CA2254079C/en not_active Expired - Fee Related
- 1997-05-01 EP EP97921345A patent/EP0902789B1/en not_active Expired - Lifetime
- 1997-05-01 BR BR9709062-0A patent/BR9709062A/pt not_active IP Right Cessation
- 1997-05-01 DK DK97921345T patent/DK0902789T3/da active
- 1997-05-01 PT PT97921345T patent/PT902789E/pt unknown
- 1997-05-01 CZ CZ19983616A patent/CZ292860B6/cs not_active IP Right Cessation
- 1997-05-01 AU AU27407/97A patent/AU721622B2/en not_active Ceased
- 1997-05-01 JP JP53994997A patent/JP3328938B2/ja not_active Expired - Fee Related
- 1997-05-01 NZ NZ332608A patent/NZ332608A/xx unknown
- 1997-05-01 HU HU9902449A patent/HUP9902449A3/hu unknown
- 1997-05-01 AT AT97921345T patent/ATE212351T1/de not_active IP Right Cessation
- 1997-05-01 WO PCT/US1997/006812 patent/WO1997042214A1/en active IP Right Grant
- 1997-05-01 DE DE69710065T patent/DE69710065T2/de not_active Expired - Fee Related
- 1997-05-01 ES ES97921345T patent/ES2171933T3/es not_active Expired - Lifetime
- 1997-05-01 RU RU98122210/04A patent/RU2194053C2/ru not_active IP Right Cessation
- 1997-05-01 CN CNB971960755A patent/CN1144812C/zh not_active Expired - Fee Related
-
1998
- 1998-11-09 NO NO19985232A patent/NO311646B1/no unknown
-
2000
- 2000-01-27 HK HK00100515A patent/HK1021539A1/xx not_active IP Right Cessation
-
2001
- 2001-11-27 NO NO20015790A patent/NO315425B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
PT902789E (pt) | 2002-07-31 |
CA2254079A1 (en) | 1997-11-13 |
NO985232L (no) | 1998-12-04 |
NO20015790D0 (no) | 2001-11-27 |
EP0902789B1 (en) | 2002-01-23 |
DK0902789T3 (da) | 2002-05-06 |
US5981517A (en) | 1999-11-09 |
JP3328938B2 (ja) | 2002-09-30 |
NO315425B1 (no) | 2003-09-01 |
EP0902789A1 (en) | 1999-03-24 |
AU2740797A (en) | 1997-11-26 |
CA2254079C (en) | 2004-09-14 |
HUP9902449A2 (hu) | 1999-11-29 |
RU2194053C2 (ru) | 2002-12-10 |
HK1021539A1 (en) | 2000-06-16 |
DE69710065D1 (de) | 2002-03-14 |
NO311646B1 (no) | 2001-12-27 |
CN1224429A (zh) | 1999-07-28 |
JP2000509716A (ja) | 2000-08-02 |
PL186637B1 (pl) | 2004-02-27 |
NO985232D0 (no) | 1998-11-09 |
EP0902789A4 (pt) | 1999-04-14 |
PL329802A1 (en) | 1999-04-12 |
ES2171933T3 (es) | 2002-09-16 |
ATE212351T1 (de) | 2002-02-15 |
CZ361698A3 (cs) | 1999-03-17 |
AU721622B2 (en) | 2000-07-13 |
HUP9902449A3 (en) | 2000-03-28 |
DE69710065T2 (de) | 2002-08-29 |
NO20015790L (no) | 1998-05-04 |
CZ292860B6 (cs) | 2003-12-17 |
CN1144812C (zh) | 2004-04-07 |
NZ332608A (en) | 2000-01-28 |
WO1997042214A1 (en) | 1997-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
FI973828A0 (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
SE9504661D0 (sv) | New compounds | |
ES2145913T3 (es) | Inhibidores de metaloproteasas. | |
AR003938A1 (es) | Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos. | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
SE9604786D0 (sv) | New compounds | |
PT948527E (pt) | Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
ATE267187T1 (de) | Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen | |
ATE78812T1 (de) | Diarylverbindungen als antiatherosklerotische mittel. | |
EA199801028A1 (ru) | Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний | |
IT1272149B (it) | Composizione farmeceutiche ad attivita' analgesica | |
BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
BR9814495A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo | |
SE9504662D0 (sv) | New compounds | |
PL339073A1 (en) | Derivatives of benzoxazine and benzothiazine and their application in therapeutic agents | |
EA199901012A1 (ru) | Фармацевтические композиции на основе тизоксанида и нитазоксанида | |
DK0981363T3 (da) | Somatostatinagonister til reduktion af legemsvægt | |
ATE286395T1 (de) | Antithrombotische mittel | |
TR199900013T2 (xx) | Yeni bile�ikler. | |
NO950177L (no) | Farmakologisk aktive erivater | |
BR9813037A (pt) | Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
BR9908155A (pt) | Composto, composição farmacêutica, uso do composto, e, processo para intensificar cognição em um sujeito sofrendo de cognição diminuìda |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
B25A | Requested transfer of rights approved |
Owner name: IVAX INTERNATIONAL GMBH (CH) Free format text: TRANSFERIDO DE: SOFT DRUGS, INC. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/12/2007, OBSERVADAS AS CONDICOES LEGAIS. |
|
B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: INPI-52400.061594/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132351-11.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: GLAXO GROUP LIMITED, GLAXO WELLCOME INC, IMMUNOTECH DEVELOPMENTS INC, IVAX INTERNACIONAL GMBH. |
|
B24H | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi) |
Free format text: EXTINCAO DEFINITIVA - ART. 78 INCISO IV DA LPI |
|
B24F | Patent annual fee: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2234 DE 29/10/2013 POR TER SIDO INDEVIDA. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A, 14A, 15A, 16A, 17A, 18A, 19A E 20A RETRIBUICAO ANUAL. |